Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > J Kenneth Zuerblis > Profile

J Kenneth Zuerblis

Affiliations

  • Director at Stemline Therapeutics Inc (STML), 2020-06-10
  • Evp, Chief Financial Officer at Savient Pharmaceuticals Inc (SVNT), 2012-02-13
  • Director at Immunomedics Inc (IMMU), 2011-12-09
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
STML $11.14 1,000 $11,142.90 11,963 2014-09-02 Filing
STML $16.38 700 $11,466.00 10,963 2013-05-30 Filing
STML $16.38 200 $3,276.00 10,263 2013-05-30 Filing
STML $15.86 1,000 $15,860.00 10,063 2013-05-29 Filing
STML $15.86 500 $7,930.00 9,063 2013-05-29 Filing